OR21-05 Primary Thyroid Lymphoma Developing from a Background of Lymphocytic Thyroiditis: First Report in Mice

por Yasuda, Yoshinori, Pani, Fabiana, Caturegli, Patrizio
Publicado 2020

Aggressive differentiated thyroid cancer with multiple metastases and NRAS and TERT promoter mutations: A case report

por Pani, Fabiana, Macerola, Elisabetta, Basolo, Fulvio, Boi, Francesco, Scartozzi, Mario, Mariotti, Stefano
Publicado 2017

MON-450 Pituitary Antibodies In A Cohort Of Us Service Members With Traumatic Brain Injury

por Pani, Fabiana, Di Dalmazi, Giulia, Corsello, Andrea, Oliver, Thomas G, Livezey, Jeffrey R, Caturegli, Patrizio
Publicado 2019

The Immune Landscape of Papillary Thyroid Cancer in the Context of Autoimmune Thyroiditis

por Pani, Fabiana, Caria, Paola, Yasuda, Yoshinori, Makoto, Miyara, Mariotti, Stefano, Leenhardt, Laurence, Roshanmehr, Solmaz, Caturegli, Patrizio, Buffet, Camille
Publicado 2022

Preconditioning of the immune system modulates the response of papillary thyroid cancer to immune checkpoint inhibitors

por Pani, Fabiana, Yasuda, Yoshinori, Rousseau, Sylvie T, Bermea, Kevin C, Roshanmehr, Solmaz, Wang, Rulin, Yegnasubramanian, Srinivasan, Caturegli, Patrizio, Adamo, Luigi
Publicado 2022

Thyrospheres from B-CPAP Cell Line with BRAF and TERT Promoter Mutations have Different Functional and Molecular Features than Parental Cells

por Caria, Paola, Pillai, Rita, Dettori, Tinuccia, Frau, Daniela Virginia, Zavattari, Patrizia, Riva, Gabriele, Romano, Gabriele, Pani, Fabiana, Bentivegna, Angela, Giovannoni, Roberto, Pagni, Fabio, Sogos, Valeria, Vanni, Roberta
Publicado 2017

Mutational and large deletion study of genes implicated in hereditary forms of primary hyperparathyroidism and correlation with clinical features

por Pardi, Elena, Borsari, Simona, Saponaro, Federica, Bogazzi, Fausto, Urbani, Claudio, Mariotti, Stefano, Pigliaru, Francesca, Satta, Chiara, Pani, Fabiana, Materazzi, Gabriele, Miccoli, Paolo, Grantaliano, Lorena, Marcocci, Claudio, Cetani, Filomena
Publicado 2017

Off-target effects and clinical outcome in metastatic colorectal cancer patients receiving regorafenib: The TRIBUTE analysis

por Giampieri, Riccardo, Prete, Michela del, Prochilo, Tiziana, Puzzoni, Marco, Pusceddu, Valeria, Pani, Fabiana, Maccaroni, Elena, Mascia, Roberta, Baleani, Maria Giuditta, Meletani, Tania, Berardi, Rossana, Lanzillo, Anna Maria, Mariotti, Stefano, Zaniboni, Alberto, Cascinu, Stefano, Scartozzi, Mario
Publicado 2017